Objective: Dexmedetomidine is an ␣-2 adrenergic agonist having wide range of effects including sedation in mammalian brain, and has analgesic as well as sympatholytic properties. This study aimed to compare the effects of dexmedetomidine and propofol infusion on sedation characteristics in patients undergoing combined sciatic nerve and femoral nerve block via anterior approach for lower limb orthopedic procedure. Methods: Forty patients, who were between 18 and 65 years old, this study was made at anesthesiology clinic of Bagcılar training and research hospital in 08 September 2011 to 07 June 2012, and underwent surgical procedure due to fractures lateral and medial malleol, were included. Sciatic nerve and femoral nerve block were conducted with an anterior approach on all patients included in the study, with an ultrasonography. The patients were randomly divided into dexmedetomidine [Group D (n = 20)
Introduction
Anxiety may lead to hypertension, arrhythmia and increase in myocardial oxygen consumption by causing higher sympathetic stimulation in patients undergoing surgical procedure under local or general anesthesia. Generally, sedation and non-surgical pain management during a surgery in patients undergoing surgical procedure under regional anesthesia has become an important issue in the anesthesiology practice. 1 Primary aim of the sedation includes providing comfort to patients, eliminating anxiety, maintenance of hemodynamic stability and restraining patient from moving. Dexmedetomidine is an ␣-2 adrenergic agonist which is more selective than clonidine and has wide range of effects including sedation in mammalian brain without causing anesthesia as well as has analgesic and sympatholytic properties. 2 The most important advantage of dexmedetomidine is lack of properties that may cause respiratory depression, although it may causes deep sedation at therapeutic doses. 3 Owing to such novel properties, dexmedetomidine may be a safer drug to provide sedation in patients undergoing peripheral nerve block. It has been used for sedation in various anesthesia procedure like MRI, spinal anesthesia involving vide range of patients including infants and children. 4 High dose of dexmedetomidine has been successfully used in pediatric magnetic resonance imaging (MRI) sleep studies. 5 Additionally, in a case report it was reported that dexmedetomidine was successfully and safely used for sedation during spinal anesthesia of a very old patient. 6 Dexmedetomidine has also been used effectively for the sedation of infants and children during spinal anesthesia in combination with ketamine preserving cardiovascular and respiratory functions. 7 Favorable results have been obtained by dexmedetomidine sedation during septoplasty surgery under local anesthesia in terms of satisfaction from anesthesia and surgery. 8 However, it has not been used for sedation in various other regional anesthesia procedures such as lower limb nerve block.
Propofol is being safely and successfully used for a long time during any intervention and imaging technique requiring sedation in patients with spontaneous respiration, as well as in regional anesthesia and peripheral nerve blocks. Various studies have shown that propofol is a preferable agent for sedation when used in combination with opioids since its efficacy starts and ends easily and dose titration is easily performed. 9, 10 Bilateral brachial plexus block has been successfully performed with propofol---ketamine sedation under ultrasonography guidance.
11
Sciatic nerve block via anterior approach can be performed under ultrasonography guidance and such an approach is very comfortable for the patient; femoral nerve block as well can be performed at the same time in the same region. 12, 13 The present study was aimed to compare the effects of intravenous continuous infusion of dexmedetomidine and propofol on the sedation characteristics of patients undergoing sciatic nerve block and femoral nerve blocks through anterior approach.
Materials and methods
After the study was approved by the local ethics committee of Yeditepe University Medical Faculty (approval date and number: 02.08.2011; 130), this study was made at anesthesiology clinic of Bagcılar training and research hospital, Istanbul, Turkey in 08 September 2011 to 07 June 2012, 40 patients, who were between 18 and 65 years old, in the American Society of Anesthesiologists (ASA) classification I---II, 14 and had undergone surgical procedure due to lateral and medial malleol fractures, were included in the study after the approval of local ethics committee and written informed patient consent were obtained. This study has been prepared in accordance with the principles of the Helsinki declaration.
Age, gender, height and weight of the patients, as well as concomitant diseases, history for drug use and smoking, anesthesia technique, surgery duration, tourniquet duration, ASA classification, systolic and diastolic blood pressures, peripheral oxygen saturation, heart rate, onset of sedation, level of sedation, time of termination of sedation, were recorded.
Inclusion criteria: The Ramsay sedation scale 15 (RSS) was used to assess the level of sedation. The modified Aldrete scoring system 16 was used to assess recovery from anesthesia. The patients having no premed were divided into two groups [Group dexmedetomidine (D; n = 20) and Group propofol (P; n = 20)] on the day of surgery according to the computerized randomization scheme. 17 Electrocardiography, non-invasive arterial blood pressure measurement and peripheral pulse oximetry were performed after the patients were admitted into the surgery room and basal values of their vital signs were recorded. For sedation, Group D received dexmedetomidine (Precedex, Abbott, Rock Mount, NC, USA) infusion at a dose of 1 g kg −1 for the first 10 min and 0.5 g kg
throughout the surgery. Patients in Group P received 2% propofol (Propofol-® Lipuro, B. Braun, Melsungen AG, Germany) at a dose of 1 mg kg −1 as the loading dose (in a minute) prior to the block and then infusion was started at a rate of 3 mg kg −1 h −1 and continued at the end of surgery. Both groups simultaneously received 0.9% NaCl at a rate of 10 mL kg −1 h −1 for the first hour and continued at a rate of 5 mL kg −1 h −1 . Vital signs were measured at 5 min intervals after dexmedetomidine or propofol infusion was started, and the time to start sedation (RSS score between 2 and 4) was recorded. Sciatic nerve block and femoral nerve block were performed 10 min after dexmedetomidine infusion and 5 min after propofol infusion via anterior approach using Stimuplex ® A (21 G 0.80---150 mm) block needles (B. Braun, Melsungen AG, Germany), of which the isolated tip was 30
• , under ultrasonography (Diagnostic ultrasound system, Model SDU 450 XL Class-1 type B, Shimadzu Corporation, Yokohama, Japan) guidance together with nerve stimulator (Stimuplex HNS nerve stimulator, Braun, Melsungen, Germany). A total of 40 mL anesthetic solution including 30 mL of 0.5% isobaric bupivacaine and 10 mL of 2% lidocaine was prepared. The nerves were stimulated by a stimulus with 2 Hz frequency and 1 mA flow; stimulus intensity was gradually decreased to 0.4 mA.
In femoral nerve block, 18 contractions of vastus medialis, vastus intermedialis and vastus lateralis were observed individually and the dispersion of local anesthetic was demonstrated by ultrasonography (linear probe) during the infusion of 20 mL of local anesthetic mixture. In sciatic nerve block, 19 when the plantar flexion, dorsiflexion and eversion of the foot were seen, the dispersion of local anesthetic was demonstrated by ultrasonography (convex probe) during the infusion of 20 mL of local anesthetic mixture.
After the block was performed in both groups, the block was evaluated by cold compress with ice battery; time to start sensory block was recorded. On the 30th min after the block, the patients were transferred for the surgery and RSS scores were recorded every 5 min. All patients were followed up by the same anesthesiologist.
Dexmedetomidine and propofol infusion rates were fixed in both groups, when needed, to fix the sedation levels between 2 and 4 according to the RSS.
Dexmedetomidine and propofol infusions were discontinued at the end of surgery and the patients were transferred to the postoperative care unit. The patients, then, transferred to the clinic when their modified Aldrete scores were ≥9.
Statistical analysis
The 10-case pre-study that we conducted showed that the mean artery pressure in the dexmedetomidine group was 82 ± 5 mm Hg and 76 ± 5 mm Hg in the propofol group; as the mean artery pressure difference is 6 mm Hg and the standard effect size is 1.2 with 95% power and 5% fallibility, n = 20 for each group. All data for the study was evaluated with the SPSS package program for Windows 11.05. All data were expressed as mean ± standard deviation. The normality analysis of the data was conducted with the Kolmogorov---Simirnov test. The study groups were also compared by chi-square test with respect to age, height, body weight, gender, ASA classification. The study groups were compared by independent sample t test in terms of arterial blood pressure, heart rate and peripheral oxygen saturation used. The study groups were also compared using the Mann---Whitney U test with Bonferroni correction with respect to sedation levels during surgery according to RSS, and time to start and end sedation. A p value <0.05 was considered statistically significant.
Results
Age (p = 0.901), height (p = 0.852), body weight (p = 0.112), gender (p = 0.714), ASA classification (p = 1000), surgery duration (p = 0.351) and Tourniquet time (p = 0.654) of the patients are presented in Table 1 . There were no significant differences between Group D and Group P in terms of these data. There were no significant differences between the groups in terms of arterial blood pressure, heart rate, and peripheral oxygen saturation measured every 5 min after dexmedetomidine or propofol infusion was started. Blood pressure values of the patients are presented in Table 2 and heart rate and peripheral oxygen saturation values are presented in Table 3 .
RSS scores measured every 5 min after the start of surgery are presented in Table 4 . There was no significant difference between the groups in terms of intraoperative RSS scores.
Mean time to start sedation (RSS scores between 2 and 4) after the start of dexmedetomidine or propofol infusion was found to be significantly longer in Group D as compared to that in Group P (8.10 ± 1.07 and 3.80 ± 0.83, respectively; p < 0.001). Time to recovery from sedation following discontinuation of dexmedetomidine or propofol infusion (modified Aldrete sedation scale score = 9) was significantly longer in Group D than that in Group P (22.30 ± 3.32 min and 9.90 ± 2.10 min, respectively, Tables 5 and 6 ; p < 0.001). With regard to adverse events, one patient in Group D developed bradycardia (<60 rate min −1 ) and was treated with 0.5 mg atropine intravenously.
Twelve patients were excluded because of inadequate block (9 sciatic and 3 sciatic + femoral).
In Group D, one patient did not even reach the RSS level of 2 with 0.5 g kg −1 h −1 dose of dexmedetomidine whereas 2 patients reached the level of RSS 5---6; however, 4 patients in the Group P had an RSS level of 5---6.
Discussion
Benzodiazepines, propofol, ␣-2 adrenoceptor agonists such as clonidine and dexmedetomidine, sevoflurane, ketamine and opioids are used to reduce procedure-associated fear and anxiety to enhance comfort to patient. 20 Although Table 5 The time it took for the Ramsay sedation scale points to achieve the range of 2 ---4 after the dexmedetomidine and propofol infusion was initiated in the groups.
Group D Group P p
Time passed for the Ramsay sedation scale points to achieve the range 2 ---4 (min)
8.10 ± 1.07 3.80 ± 0.83 * <0.001 D, dexmedetomidine; P, propofol. Data are expressed as mean ± standard deviation. * When Group D and Group P are compared in terms of their Ramsay sedation scale points achieving the range of 2 ---4 after the infusion of dexmedetomidine and propofol was initiated, this period was longer in Group D than in Group P and there were statistically significant differenced present between Group D and Group P, <0.001.
Table 6
The time it took for the modified Aldrete sedation scale points to achieve 9 after the dexmedetomidine and propofol infusion was suspended.
Group D Group P p
Time passed for the modified Aldrete sedation scale points to achieve 9 (min)
22.30 ± 3.32 9.90 ± 2.10 * <0.001 D, dexmedetomidine; P, propofol. Data are expressed as mean ± standard deviation. * When Group D and Group P are compared in terms of their modified Aldrete sedation scale points achieving 9 after the infusion of dexmedetomidine and propofol was suspended, this period was longer in Group D than in Group P and there were statistically significant differenced present between Group D and Group P, <0.001.
dexmedetomidine is being used in intensive care units for a long time for sedation, there is limited information about its use for intraoperative sedation. 4 In the present study, we aimed to evaluate whether dexmedetomidine can be used for sedation during peripheral nerve block and to investigate the effects of dexmedetomidine on sedation characteristics in comparison to propofol.
Dexmedetomidine is an ␣-2 receptor agonist. Studies have shown that ␣-2 receptor agonists have analgesic, sedative---hypnotic and sympatholytic properties. 21, 22 There are studies suggesting that dexmedetomidine is an effective drug in intraoperative sedation. 23, 24 Shehabi et al. 25 performed dexmedetomidine infusion (0.2---0.7 g kg −1 h −1 ) for an average of 71.5 h for sedation of 60 critical patients in the intensive care unit with a fixed dose infusion to achieve score between 2 and 4. They fixed the infusion dose that RSS score would be between 2 and 4. They concluded that dexmedetomidine can be used for an effective sedation and as a substitute analgesic in critical patients without causing significant changes in vital signs within 24 h period. In the present study, we used dexmedetomidine for sedation during anterior sciatic nerve block in combination with femoral nerve block. We fixed the dexmedetomidine infusion dose to be 0.5 g kg −1 h −1 and applied a loading dose of 1 g kg −1 for 10 min prior to the infusion; thus, In our study, 2 out of 23 patients had reached the level of RSS 5 ---6 with 0.5 g kg −1 h −1 dose of dexmedetomidine; however, these patients did not develop respiratory depression and their vital findings were within physiological limits. No significant change was observed in the vital signs of the patients in Group D and vital signs were also similar to that of Group P.
Intravenous use of sedative and hypnotic drugs during regional anesthesia as supportive medication enhances patient comfort 26, 27 with minimum morbidity and mortality and maintains cardiovascular stability by lowering perioperative stress. 28 In the present study, we aimed to enhance patient comfort with dexmedetomidine and propofol infusion and observed that the similar sedation had been achieved in Group D as compared to that in Group P.
An ideal sedation during regional anesthesia requires an open airway, a reliable sleep state, minimally influenced cardiovascular system, and a rapid recovery period from anesthesia.
1 MRI sleep studies conducted on the children with obstructive sleep apnea have demonstrated that dexmedetomidine requires low rate of airway intervention as compared to propofol. Although dexmedetomidine has caused significant decrease in heart rate and propofol has caused significant decrease in arterial blood pressure, the procedure has not been discontinued and MRI sleep study has been completed successfully. 29 In the present study, none of the patients required airway support and no significant difference was observed between the groups in terms of vital signs. However, time to recovery from anesthesia was found significantly longer in Group D as compared to Group P.
Intraoperative sedation during regional anesthesia enhances the quality of local and regional anesthesia by providing optimum patient comfort with minimum morbidity and mortality. Nevertheless, it is very difficult to provide adequate level of sedation due to the variabilities in the patient expectations regarding sedation level, differences in intraoperative conditions, and pharmacokinetic and pharmacodynamic properties of the agents. In the present study, we tried to preserve the adequate level of sedation by successful adjustment of infusion rates of dexmedetomidine and propofol. The RSS scores of the patients were found to be similar in both study groups.
It is stated that dexmedetomidine is frequently used for sedation in intensive care units and that it is an agent with which patient cooperation is better as compared to other drugs. 30, 31 In the present study, the level of sedation was kept between 2 and 4 according to RSS and no significant difference was obtained between the study groups in terms of sedation at that level; thus, the cooperation levels of the study groups were found to be similar.
Dexmedetomidine provides dose-dependent sedation and prolongs the sensorial block. However, it has been stated that dexmedetomidine may cause unintended hemodynamic impairment, and nausea and vomiting. 31 Neither nausea, vomiting nor unintended hemodynamic impairment was observed in the present study.
Intravenous ␣-2 adrenoceptor agonist administration causes a decrease in heart rate, and temporary increase in arterial blood pressure and systemic vascular resistance due to the activation of postjunctional vascular ␣-2 adrenoceptors. Subsequently, long-term decrease in heart rate and blood pressure is observed due to the decrease in central sympathetic tonus and vagal activity. 4, 31 Dexmedetomidine provides a predictable stable hemodynamics when administered as continuous infusion. In the present study, blood pressure and heart rate values were found similar in both study groups. In Group D, one patient developed bradycardia and was treated with 0.5 mg atropine intravenously. Moreover, patients with hypovolemia, vasoconstriction or severe cardiac block had already been excluded from the study since they were likely to develop hypotension and bradycardia.
The most important advantage of dexmedetomidine is that it dose not cause respiratory depression, although it may cause deep sedation at therapeutic doses. 3, 32, 33 In our study, 2 out of 23 patients in Group D had reached the level of RSS 5 ---6 with 0.5 g kg −1 h −1 dose of dexmedetomidine; however, these patients did not develop respiratory depression and their vital findings were within physiological limits.
There are similar studies, which used dexmedetomidine for intraoperative sedation in awake patients. 24, 25 Arain et al. 17 compared dexmedetomidine and propofol during intraoperative sedation and found no difference in psychomotor performance and respiratory rate during recovery. They also found that later onset and termination of sedation was observed in the dexmedetomidine group as compared to the propofol group, whereas postoperative analgesia was better and analgesic consumption was lower in the dexmedetomidine group. In the present our study, the effects of dexmedetomidine and propofol on the postoperative analgesic characteristic of sciatic---femoral block were found similar since half-lives of dexmedetomidine and propofol was shorter than action time of sciatic---femoral block. However, consistent with the above-mentioned study, later onset and termination of sedation was observed in dexmedetomidine group than propofol group in the present study.
Limitation
The result of the primary measurement of this study is the RSS values after dexmedetomidine and propofol sedation. Future studies that show that dexmedetomidine can be used for sedation during the intra-operative period and that present the effects of dexmedetomidine on the characteristics of the sciatic---femoral block with an anterior approach should be encouraged. The RSS used to identify the degree of sedation is subjective; it is limited due to the patient providing verbal evaluations. RSS is a subjective measurement; however, it has been described previously. 15 RSS does not provide objective data regarding the sedation status of the patient. RSS values depend on the particular pharmaco-dynamic and pharmaco-kinetic characteristics of the sedative drug on different people. 34 The patients' vital findings were evaluated and their compatibility with the RSS values were compared. Verbal dialogs were continued with the patient in order to perform a correct and accurate sedation evaluation. The patients were informed on RSS before the operation. The RSS inquiry was performed on all patients by the same anesthetist. Future studies will study using objective methods to identify the degree of sedation while intra-operatively using dexmedetomidine.
Conclusion
In conclusion, it was observed that sedation could be achieved in the range of RSS 2 ---4 via dexmedetomidine at a dose of 0.5 g kg −1 h −1 or propofol infusion at a dose of 3 mg kg −1 h −1 administered for sedation purposes on patients undergoing sciatic---femoral nerve block with an anterior approach. It was considered that dexmedetomidine had propofol-like effects on patients undergoing a sciatic---femoral nerve block with an anterior approach and that it could be used in place of propofol. However, it was observed that some patients could have RSS levels of 5 ---6 via the infusion of dexmedetomidine at a dose of 0.5 g kg −1 h −1 or propofol at a dose of 3 mg kg −1 h −1 . Similarly, it was observed that some patients could experience inadequate sedation via dexmedetomidine infusion. It was observed that the time between sedation onset and ending with dexmedetomidine at a dose of 0.5 g kg −1 h −1
was longer than sedation time induced via propofol at a dose of 3 mg kg −1 h −1 at a statistically significant level for patients undergoing sciatic---femoral nerve block with an anterior approach.
